It’s been over a year since renal denervation systems for the treatment of hypertension became available to US physicians, ...

While no impacts were seen on morbidity or mortality, the data provide evidence to the theory that “familiarity breeds ...

The new data may spark fresh debate over alcohol’s once-celebrated cardioprotective benefits: not everyone is convinced.

The US data suggest that the South has seen the greatest shifts, and the highest rate of GLP-1 prescribing per capita.

More work is needed to understand how to act preemptively on elevated heart failure risk, one researcher says.

PET/CT findings that link anabolic-androgenic steroids to reduced myocardial flow may point to a mechanism for heart damage.

Touchy topics, timely analysis, tips for tackling entrenched problems: enjoy some of TCTMD’s best features this year.

Two pacing-dependent patients have died: an increased risk of permanently entering Safety Mode has been identified.

Mamas Mamas, Nieves Gonzalo, and Erick Schampaert review the latest guidance on chronic coronary syndromes, with an eye to the shifting role of complex PCI.

Patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and high body mass index ...

The findings hint at the potential need for serial measurements in patients who are being considered for Lp(a)-lowering therapies.